Barclays analyst Raimo Lenschow has reiterated his Equal-Weight rating on Couchbase and increased the price target to $33, up from...

Nuvei Corporation has announced impressive financial performance for the fourth quarter and fiscal year ending March 6, 2024, with a...

Applied Therapeutics is optimistic about its financial position as of March 6, 2024. With $49.9 million in cash and cash...

Analysts Bullish on Ross Stores Post Q4 Results Following Ross Stores, Inc.'s impressive fourth-quarter results, analysts have raised their forecasts...

Xeris Biopharma announced a total revenue of $163.9 million for the fiscal year ending on March 6, 2024. The company...

Creative Medical Technology Holdings, Inc. announced on March 6, 2024, that they have been granted FDA Orphan Drug Designation for...

Xeris Biopharma Holdings (NASDAQ:XERS) announced their fourth-quarter financial results on March 6, 2024. The company reported a GAAP EPS of...

Trinity Capital Inc. (NASDAQ: TRIN) has announced impressive financial results for the fourth quarter of 2023. The company's earnings per...

Gleaming with optimism, Guggenheim analyst Robert Drbul reaffirms his Buy rating on Target (NYSE:TGT) as he boosts the price target...

United Natural Foods has revised its fiscal year 2024 forecast on March 6, 2024. The company has narrowed its projected...